Sigma-1 Receptor Chaperones and Diseases

E-ISSN： 1875-6166|9|3|184-189

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.9, Iss.3, 2009-09, pp. : 184-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases

Current Neuropharmacology, Vol. 16, Iss. 1, 2017-12 ,pp. : 97-116

Bentham Science Publishers

Access to resources Recommend Favorite

Sigma-1 Receptor Agonists as Therapeutic Drugs for Cognitive Impairment in Neuropsychiatric Diseases

Current Pharmaceutical Design, Vol. 18, Iss. 7, 2012-03 ,pp. : 875-883

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands

Current Neuropharmacology, Vol. 6, Iss. 4, 2008-12 ,pp. : 344-366

Bentham Science Publishers

Access to resources Recommend Favorite

Immunophilin Chaperones in Steroid Receptor Signalling

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 12, 2003-08 ,pp. : 1348-1357

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting sigma-1 receptor signaling by endogenous ligands for cardioprotection

By Bhuiyan Md. Shenuarin Fukunaga Kohji

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 145-155

Informa Healthcare

Access to resources Recommend Favorite